Work

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation

Year: 2021

Type: article

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2021.105182

Authors: Kirk Chan-Tack, Patrick Harrington, Timothy Bensman, Su-Young Choi, Eric Donaldson, Julian O'Rear, David McMillan, Laine Myers, Mark Seaton, Hanan Ghantous, Yu Cao, Thamban Valappil, Debra Birnkrant, Kimberly Struble

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Poxvirus research and outbreaks

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Food and Drug Administration

OpenAlex ID: W3203376403

FWCI: 8.4

Cites: 13

Cited by: 81

Related to: 10